Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982604 · ClinicalTrials.gov registry record · Phase 1
Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers
A Phase 1 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01982604 is a Phase 1 study that has completed, run by Mannkind Corporation. The registered enrollment target is 38 participants.
The verdict
NCT01982604, a Phase 1 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
A Phase 1, open-label randomized crossover trial in Healthy Volunteers to evaluate the PK/PD of TI (Technosphere® Insulin) prepared with insulin from two different suppliers.
Interventions
- DRUG TI-Inhalation Powder A
- DRUG TI-Inhalation Powder B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01982604
The ClinicalTrials.gov registry entry for NCT01982604 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TI-Inhalation Powder A is the first listed.
NCT01982604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01982604 about?
NCT01982604 is a clinical study titled "Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers". A Phase 1, open-label randomized crossover trial in Healthy Volunteers to evaluate the PK/PD of TI (Technosphere® Insulin) prepared with insulin from two different suppliers.
What is the current status of trial NCT01982604?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2013-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01982604?
The interventions under investigation include: TI-Inhalation Powder A (DRUG), TI-Inhalation Powder B (DRUG).
Who is sponsoring clinical trial NCT01982604?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.